CVS · Full Picture

CVS HEALTH Corp — the full picture

Earnings window · 2026-07-15 to 2026-08-09 · anchored on the 10-Q report

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

  1. Revenue Performance and Mix · Revenue growth & mixPriority 78
    +106.8% revenue (realized); 3 sources (news, press_release, sec_filing); structured_verified
    Consolidated net income attributable to CVS Health for six months ended June 30, 2026: $5,922 million versus $2,800 million in 2025
  2. Liquidity and Cash Position · Liquidity & cash positionPriority 64
    2 sources (press_release, sec_filing); 1 forward row(s); structured_verified
    Net cash provided by operating activities for the six months ended June 30, 2026 was $10,594 million, an increase of $4,141 million or 64.2% versus prior year.
  3. Debt and Capital Allocation · Debt, leverage & refinancingPriority 61
    quote_verified
    Long-term debt at June 30, 2026: $59,452 million versus $60,502 million at December 31, 2025
  4. Operating Expense Trends · Operating expenses (SG&A)Priority 59
    -0.1% operating_income; 2 sources (press_release, sec_filing); 1 forward row(s); quote_verified
    Operating expenses consolidated for Q2 2026: $11,046 million versus $11,212 million in Q2 2025
  5. Liquidity and Debt Position · Debt, leverage & refinancingPriority 58
    -1.4% cash (realized); 2 sources (news, sec_filing); 2 forward row(s); structured_verified
    Raised full-year 2026 cash flow from operations guidance to at least $11.5 billion from at least $9.5 billion.
  6. Pharmacy Demand And Pricing · Demand, orders & backlogPriority 58
    2 sources (press_release, sec_filing); quote_verified
    The Company completed Rite Aid asset acquisitions during the third quarter of 2025 and those contributed to increased prescription volume in Q2 2026
  7. Operating Income and Margins · Operating income & profitabilityPriority 57
    +5.6% operating_income (realized); structured_verified
    Consolidated operating income for the three months ended June 30, 2026 was $4,703 million, up $2,322 million or 97.5% versus prior year.
  8. Medical Cost Trend / Benefit Ratio · Input & product costsPriority 53
    -2.5% margin (realized); 3 sources (news, press_release, sec_filing); structured_verified
    Health care costs (consolidated) for Q2 2026: $31,485 million versus $31,317 million in Q2 2025
  9. Segment Profitability · Operating income & profitabilityPriority 53
    +5.0% operating_income (realized); 2 sources (news, press_release); quote_verified
    CVS Health reported a significant surge in its second-quarter net income, nearly tripling to $2.9 billion.
  10. Guidance and Outlook · Guidance & outlookPriority 51
    2 sources (news, press_release); 4 forward row(s); quote_verified
    Consolidated projected net income attributable to CVS Health for year ending December 31, 2026: low $8,810 million ($6.84 per share) to high $9,065 million ($7.04 per share)
  11. Capital Return Program · Buybacks & dividendsPriority 50
    qualitative only
  12. Government Membership Growth · Customers & concentrationPriority 50
    quote_verified
    Health Care Benefits total revenues increase of 3.5% for Q2 2026 was primarily driven by an increase in the Government business and partially offset by exit of the individual exchange business in 2026

Threads by pillar

Revenue & Demand Priority 88 · 6 threads

Costs & Margins Priority 80 · 6 threads

Capital & Balance Sheet Priority 83 · 6 threads

Strategy & Portfolio Priority 36 · 2 threads

Legal, Regulatory & Policy Priority 59 · 5 threads

Guidance & Outlook Priority 59 · 2 threads

Macro & Market Conditions Priority 33 · 1 thread

Unclassified Priority 72 · 5 threads

Expected impact by metric

metricforward netforward grossrealized
net_income+0.3%+0.4%+9.0%
operating_income-0.1%+0.1%+2.0%
cash——-1.4%
margin——-2.5%
revenue——+109.6%